Anmelden Kostenlos registrieren

Apellis Pharmaceuticals Inc Einnahmen

Was ist das Einnahmen von Apellis Pharmaceuticals Inc?

Einnahmen von Apellis Pharmaceuticals Inc ist 240.74%

Was ist die Definition von Einnahmen?

Das jährliche Umsatzwachstum der letzten 3 Jahre ist das durchschnittliche Umsatzwachstum der letzten 3 Jahre von einem Jahr zum nächsten.

The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.

Einnahmen von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Apellis Pharmaceuticals Inc

Was macht Apellis Pharmaceuticals Inc?

apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.

Unternehmen mit einnahmen ähnlich Apellis Pharmaceuticals Inc